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Infections of the bloodstream, central nervous system, peritoneum, joints, and other
sterile areas are associated with high morbidity and sequelae risk. Timely initiation
of effective antimicrobial therapy is crucial to improving patient prognosis. However,
standard final identification and antimicrobial susceptibility tests (ASTs) are reported
16–48 h after a positive alert. For a rapid, effective and low-cost diagnosis, we combined
matrix-assisted laser desorption/ionization time of flight mass spectrometry with a Vitek
AST system, and performed rapid microbial identification (RMI) and rapid multiple AST
(RMAST) on non-duplicated positive body fluid cultures collected from a hospital in
Shanghai, China. Sterile body fluid positive culture and blood positive culture caused
by Gram negative (GN) or polymicrobial were applied to the MALDI–TOF measurement
directly. When positive blood culture caused by Gram positive (GP) bacteria or yeasts,
they were resuspended in 1ml brain heart infusion for 2 or 4 h enrichment, respectively.
Regardless of enrichment, the RMI (completed in 40min per sample) accurately identified
GN and GP bacteria (98.9 and 87.2%, respectively), fungi (75.7%), and anaerobes
(94.7%). Dominant species in multiple cultures and bacteria that failed to grow on
the routing plates were correctly identified in 81.2 and 100% of cases, respectively.
The category agreements of RMAST results, determined in the presence of various
antibiotics, were similarly to previous studies. The RMI and RMAST results not only
reduce the turnaround time of the patient report by 18–36 h, but also indicate whether
a patient’s antibiotic treatment should be accelerated, ceased or de-escalated, and
adjusted the essential drugs modification for an optimized therapy.
Keywords: MALDI-TOF mass spectrometry, Vitek AST system, sterile body fluids positive culture, rapid diagnosis,
clinical impact
Abbreviations: A list of abbreviations is shown in Table S2 in Supplementary Material.
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INTRODUCTION
Infections of the bloodstream, central nervous system,
peritoneum, joints, and other sterile areas are associated
with high morbidity and risk of sequelae (Thigpen et al., 2011;
Goto and Al-Hasan, 2013; Chon et al., 2014; Ascione et al.,
2015; Bagheri-Nesami et al., 2015). Among these, bloodstream
infection (BSI) is most serious, because it can rapidly deteriorate
into sepsis, severe sepsis, or septic shock. BSIs have become a
major cause of death in European intensive care units, incurring
a mortality rate of 30–50% (Vincent et al., 2006). To improve this
prognosis, timely initiation of effective antimicrobial therapy is
essential (Kumar et al., 2006; Vincent et al., 2006; Dellinger et al.,
2013; Chon et al., 2014; Ascione et al., 2015; Bagheri-Nesami
et al., 2015). Currently, culture remains the gold standard of
infection diagnosis. However, standard final identification (ID)
and ASTs are reported 16–48 h after a positive alert. During this
delay, the clinician must administer an empirical antimicrobial
therapy, typically a broad-spectrum antibiotic or an antibiotic
cocktail to cover all likely pathogens. However, inappropriate
antimicrobial therapy will worsen the outcome (Ibrahim et al.,
2000; Tumbarello et al., 2010; Cain et al., 2015). Moreover,
the long-term use of dispensable broad-spectrum antibiotics
promotes antibiotic resistance and spread, increases cost and
lengthens hospital stays (Blot et al., 2002; Tumbarello et al.,
2010).
Matrix-assisted laser desorption/ionization time of flight
mass spectrometry (MALDI–TOF MS) promises a revolutionary
breakthrough in clinical microbiology. The technology identifies
bacteria within 6min (Seng et al., 2009), with a species-level
accuracy of 84.1–93.6% (Bizzini and Greub, 2010) and high
sensitivity (∼105 CFU). Currently, MALDI-TOF MS has shown
the ability to distinguish vanB-positive Enterococcus faecium
from isolates that do not possess this resistance gene (Griffin
et al., 2012) and demonstrate the carbapenemase activity by
detection of meropenem and the relevant degradation products
(Hrabak et al., 2011). Another study focused on a proteome
analysis of ampicillin-resistant Fusobacterium nucleatum was
reported (Al-Haroni et al., 2008). Moreover, MALDI-TOF
MS fingerprinting has been used to distinguish the different
expression levels of cell wall components between resistant
isolates and sensitive isolates (Xu et al., 2006). Recently,
RMI by MALDI–TOF MS has been adopted in various
protocols, including the commercial Sepsityper kit (Bruker
Daltonics, Bremen, Germany; Martiny et al., 2012; Hazelton
et al., 2014; Idelevich et al., 2014; Martinez et al., 2014;
Schieffer et al., 2014; Morgenthaler and Kostrzewa, 2015),
serum separator tubes (Stevenson et al., 2010; Schubert
et al., 2011) and in-house methods (Martiny et al., 2012).
These techniques return the RMI from positive bottles within
30min to a few hours. They also reliably identify species-
level GN and GP bacteria (with accuracies of 90 and 76%,
respectively) and yeasts (66%) (Morgenthaler and Kostrzewa,
2015). However, the Sepsityper kit is expensive, whereas the
in-house method involves multi-step washing/centrifugation
and yields relatively low RMI accuracy for GP bacteria and
yeasts.
Rapid ASTs have been attempted in several studies. For
instance, methicillin-resistant staphylococci and vancomycin-
resistant enterococci have been detected in real-time PCR–
melt curve analysis (Chan et al., 2015). MALDI–TOF MS can
detect subtle differences in isogenic Staphylococcus aureus, which
determine the organism’s resistance to methicillin or teicoplanin
(Majcherczyk et al., 2006), ampicillin susceptibility (Grundt et al.,
2012), and carbapenemase (Hrabák et al., 2012). All of the
above methods are efficient; however, molecular methods cannot
identify the expression of resistance genes, and other methods
are limited to one or a few specific antibiotic determination
profiles.
To overcome these difficulties, we determined the RMI and
RMAST by a combined MALDI–TOF MS/Vitek AST system.
Bacterial cells were directly extracted from positive sterile body
fluid cultures in serum separator tubes, and proliferated in brain
heart infusion broth (BHI) for 2–4 h.
This study aims to evaluate the reliability and accuracy of this
protocol in fast pathogen diagnosis without additional costs and
efforts.
MATERIALS AND METHODS
Location
This study was conducted in Huashan Hospital (affiliated
with Fudan University), located in the center of Shanghai,
China. Huashan Hospital is one of the largest (1300 beds)
comprehensive teaching hospitals in China, handling ∼8000
admissions per day.
Clinical Samples
Sterile body fluids, including blood, cerebrospinal fluid (CSF),
pleural fluid, ascitic fluid, pericardial effusion, joint cavity fluid,
and vitreous fluid, were injected into blood culture bottles to
improve the positive rate of clinical samples. From September
2014 to August 2015, we enrolled the first positive culture from
each patient. Thus, we collected 485 non-duplicated positive
cultures.
Blood Culture (BC) Bottles and BC System
The BC bottles were BacT/Alert aerobic/SA and anaerobic/SN
(bioMérieux, Marcy l’Etoile, France), and BACTEC Plus
Aerobic/F, BACTEC Plus Anaerobic/F and BACTEC Mycosis-
IC/F (Becton Dickinson, USA; Figure S1). All bottles were
incubated in automated BC systems (BacT/Alert 3D, bioMérieux
and BACTEC FX, Becton Dickinson; Figure S1) until they tested
positive. Positive cultures were analyzed immediately after a
positive alert during laboratory hours (8 a.m. to 5 p.m.). Cultures
that became positive later than this period were stored in the BC
systems and analyzed the next morning.
Positive Cultures Processing for RMI
Analysis and RMAST
Based on the Gram staining results, 5ml (sterile body fluid
positive culture and blood positive culture caused by GN or
polymicrobial) or 10ml (blood positive culture caused by other
bacteria) were drawn into one or two serum separator tubes
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(BD Vacutainer SSTII Advance, USA). Bacteria were pelleted
by centrifugation at 4000 g for 10min. The bacteria became
aggregated at the surface of the polymeric gel, while the red-
blood-cell component was sedimented beneath the gel layer. The
supernatant was discarded and the bacterial pellet was gently
resuspended in 1ml sterile distilled water, without disrupting the
gel layer. The suspension was transferred to a sterile Eppendorf
tube, mixed thoroughly, and centrifuged at 16,000 g for 1min.
The supernatant was discarded and the washing/centrifugation
steps were repeated once. The pellets were resuspended in 100µl
sterile distilled water. A portion of the resuspension was drawn
and subjected to an ethanol/formic acid extraction procedure.
The rest of the resuspension was prepared for 0.5 McFarland
(McF) and subjected to RMAST as described for standard AST.
Prior to the ethanol/formic acid extraction, pellets of blood
cultures caused by other bacteria (but not those caused by GN
or polymicrobial) were resuspended in 1ml BHI for enrichment.
GP bacteria and yeasts were inoculated at 37◦C with shaking
at 200 rpm for 2 and 4 h, respectively. The enrichments were
pelleted at 16,000 g for 1min. After discarding the supernatant,
the pellets were washed with 1ml sterile distilled water, and re-
centrifuged at 16,000 g for 1min. Again, the supernatant was
discarded.
In the ethanol/formic acid extraction procedure, a portion
of the bacterial pellet was resuspended in 300µl water by
vortexing. The suspension was thoroughly mixed with 900µl
absolute ethanol and then centrifuged at 16,000 g for 1min.
The supernatant was discarded and the residual ethanol
was removed after a repeat centrifugation. The cell pellet
was air dried and dissolved in 30µl of 70% formic acid
by thorough vortexing. After adding 30µl acetonitrile, the
dissolved pellet was centrifuged at 16,000 g for 2min and
1µl supernatant was spotted onto a steel target plate for
MALDI–TOFMS (Bruker Daltonics, Bremen, Germany) analysis
(Figure 1).
Standard Identification and Antimicrobial
Susceptibility Testing
The positive broths were sub-cultured onto routing plates of 5%
sheep blood agar, chocolate, or anaerobic blood agar. Bacteria
that failed to grow on the routing plates were inoculated
on self-made plates composed of 20ml sterile blood culture
broth (bioMérieux, Marcy l’Etoile, France; Becton Dickinson,
USA) and 3.9% agar powder (Oxoid, Thermo Fisher Scientific,
England). Plates were grown in the incubator (Thermo Scientific
Forma, USA) at 35◦C in 5% CO2 or an anaerobic atmosphere
until visible colonies appeared. A pure bacterial colony was
smeared onto a steel target plate for identification by MALDI–
TOF MS. For yeasts, 1µl of formic acid was added to the plate
and air dried for 5min.
In the antimicrobial susceptibility testing, Vitek cards AST-
GN13, AST-Gp67, and AST-Gp68 were used for GN bacteria,
staphylococci/enterococci and Streptococcus pneumoniae,
respectively. Other streptococci and yeasts were tested with
ATB-STREP5 and ATB-FUNGUS3 (bioMérieux, Marcyl’
Etoile, France), respectively. The GN bacteria, staphylococci,
enterococci, streptococci, or yeast pellets were dissolved in 0.45%
saline solution to prepare 0.5–0.63 McF or 2 McF suspension,
respectively. The Vitek card AST-GN13 or AST-Gp67/AST-
Gp68 were filled with suspension composed of 3ml 0.45%
saline solution and 145 or 280µl 0.5–0.63 McF suspension,
respectively. The ATB-STREP5 strip was filled with suspension
composed of ATB S medium and 200µl 0.5 McF suspension.
The ATB-FUNGUS3 strip was filled with suspension composed
of ATB F2 medium and 20µl 2McF suspension.
FIGURE 1 | Workflow of positive culture processing for RMI/RMAST analysis.
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Matrix-Assisted Laser
Desorption/Ionization-Time of Flight Mass
Spectrometry
The spot was overlaid with 1µl MALDI matrix (a saturated
solution of α-cyano-4-hydroxycinnamic acid in 50% acetonitrile–
2.5% trifluoroacetic acid). After drying at room temperature for
5min, sample was subjected to analysis of the bacteria protein
using MALDI-TOF MS system. The spectrum was obtained in
linear positive-ion mode range from 2000 to 20 000 Da. Each
spot was measured manually on five different positions by using
1000 laser shots at 25Hz in groups of 40 shots. The MALDI
Bruker Biotyper 3.0 software and library (Bruker Daltonics) were
used for spectra analysis. According to the spectra matching and
score criterion, MALDI Bruker Biotyper 3.0 software obtained
appropriate scores and identification results. The workflow was
shown in Figure 2A.
Interpretation of RMI and RMAST
RMI results were scored by the manufacturer’s standard criterion
(cut-off values of 1.7 and 2.0 for acceptable identification
to the genus and species levels, respectively) and by the
modified criterion (cut-off values of 1.5 and 1.8 for at least
three identical results in the list at the genus and species levels,
respectively). These criteria have been described in previous
studies (Schmidt et al., 2012; Machen et al., 2014; Martinez et al.,
2014; Morgenthaler and Kostrzewa, 2015). The RMI results
were compared with the final reports. Non-identifiable samples
included correctly identified samples with scores below the
genus level cut-off value and samples that presented no peak or
a very weak signal. Discordant identification included samples
that the RMI results were inconsistent with the final reports
which proved correct. Discrepancies were resolved by 16S rRNA
(for bacteria; primer F, 5′-AGAGTTTGATGATGGCTCAG-
3′; primer R, 5′-ACCGCAACTGCTGGCAC-3′; expected
PCR product size: ∼800 bp) or 18S rRNA (for fungi;
primer F, 5′-GATACCGTCGTAGTCTTA-3′; primer R, 5′-
ATTCCTCGTTGAAGAGC-3′; expected PCR product size:
∼800 bp) amplification. DNA was extracted from colonies
sub-cultured for 24 h using Genomic DNA isolation kit (Sangon
Biotech, Shanghai, China). Thermal cycler conditions were 94◦C
for 5min, followed by 35 cycles of 94◦C (30 s), 55◦C (30 s), and
72◦C (30 s), with a final extension at 72◦C (7min).
RMAST results were compared with those obtained from
the standard method. The minimum inhibitory concentrations
(MIC) obtained by both methods were translated into clinical
FIGURE 2 | (A) The RMI workflow of MALDI-TOF MS system. (B) RMI spectra of representative bacterial species.
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categories (susceptible, intermediate, resistant), following the
CLSI recommendations. The comparison between the direct and
standard inoculation methods was categorized as agreement,
very major error (VME, false susceptibility), major error (ME,
false resistance), or minor error (mE, susceptible/resistant
versus intermediate susceptibility). Discrepancies in MICs were
resolved by broth dilution methods according to the CLSI (2015)
guidelines.
Evaluation of Clinical Relevance
To prevent the development of resistance, to reduce toxicity, and
to reduce costs, the antimicrobial regimen should be ceased when
detected typical contaminants (Monoculture grew Coagulase-
negative staphylococcus among multiple cultures, Micrococcus
spp,Corynebacterium spp, Bacillus spp, Propionibacterium acnes)
and assessed for potential de-escalation (De-escalation refers
to narrow the spectrum of antimicrobial coverage and choose
the most appropriate single-agent therapy). Antibiotic therapy
should be installed when detected pathogenic species that cannot
be distinguished by Gram staining and modified when detected
intrinsic resistant bacteria (Bacteria were intrinsic antibiotic-
resistance. Stenotrophomonas maltophilia, Enterococcus
casselifavus, and Candida glabrata are intrinsic resistant to
carbapenem, vancomycin, and fluconazole, respectively) or
acquired resistant bacteria (Antibiotic-resistance was mediated
by plasmid, resistant enzymes, or other resistance mechanisms).
RMI/RMAST results were reported to the clinician. To assess
the impact of our approach on the management of sterile body
infections, we determined whether the results can instructively
recommend an optimal therapeutic scheme. Unreliable results
were excluded. Indications leading to a treatment change are
listed in Table 1.
Statistical Analysis
Statistical time comparisons were conducted by a Wilcoxon
signed-rank test (GraphPad Prism 5.0, CA, USA). P < 0.05
was considered statistically significant. All statistical tests were
two-tailed.
RESULTS
Rapid Microorganism Identification
Regardless of enrichment, the RMI test of each
sample was completed in 40min (15min for the pellet
collection/washing/centrifugation steps, 15min for the
extraction procedure, 5min for the sample spotting/drying
steps, 5min for MALDI–TOF MS measurement). The
RMI was evaluated in 485 non-duplicated positive cultures
TABLE 1 | Indications for optimized antibiotic therapy and recommendations based on RMI /RMAST results.
RMI result RMAST result
(0.58–4.58 h) (8.4–34 h)
Cessation of antibiotic therapy Detection of typical contaminants:
* Monoculture grew Coagulase-negative staphylococcus among
multiple cultures
* Micrococcus spp.
* Corynebacterium spp.
* Bacillus spp.
* Propionibacterium acnes
Installation of antibiotic therapy Detection of pathogenic species that cannot be distinguished by
Gram staining:
Assessment and verification the initiated measure.
* Staphylococcus aureus
* Staphylococcus lugdunensis
* Listeria monocytogenes
Modification of antibiotic therapy Detection of intrinsic resistant bacteria: Assessment and verification the initiated measure.
* Stenotrophomonas maltophilia with carbapenem resistance
* Enterococcus casselifavus with vancomycin resistance
* Candida glabrata with fluconazole resistance
De-escalation antibiotic therapy De-escalation of broad spectrum antibiotics or last-resort
antibiotics (carbapenems, vancomycin, linezolid) or combination
therapy in case of results indicates low-risk intrinsic resistant
bacteria (e.g., Escherichia coli, Staphylococci) associated with
negative acquired antibiotic-resistant history.
Modification of antibiotic therapy Detection of acquired resistant bacteria (e.g., carbapenem
resistant GN bacteria, vancomycin, or linezolid non-susceptible
Enterococci and Staphylococci).
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(Table 2). The compositions of the positive cultures are listed in
Table S1.
The RMI spectra of representative bacterial species were
shown in Figure 2B. Scored by the standard criterion, the correct
identification rates of RMI were 96.3% for GN bacteria (182/189),
82.8% for GP bacteria (168/203), 11.8% for fastidious bacteria
(2/17), 62.2% for fungi (23/37), and 89.5% for anaerobic bacteria
(17/19). In cultures of polymicrobial, the dominant bacterium
was correctly identified in 81.2% (13/16) of cases and bacteria
that failed to grow on the routing plates were identified with
a success rate of 50.0% (2/4). Scored by the modified criterion,
the correct identification rates of RMI were 98.9% (187/189) for
GN bacteria, 87.2% (177/203) for GP bacteria, 11.8% (2/17) for
fastidious bacteria, 75.7% (28/37) for fungi, and 94.7% (18/19) for
anaerobic bacteria (18/19). In cultures containing polymicrobial
and bacteria that failed to grow on the routing plates, the
correct identification rates were 81.2% (13/16; dominant species)
and 100.0% (4/4), respectively. The modified criterion provided
more accurate RMI scores than the standard criterion, with no
relevant misidentification at the genus level (Tables 2, 3). The
RMI accuracy was lower in blood samples than in other sterile
body fluids (Table S1). The mean RMI scores and the RMI results
of polymicrobial are listed in Tables 2, 3, respectively.
Rapid Antimicrobial Susceptibility Test
Among the 320 non-duplicated positive cultures, 140 GN
bacteria, 105 Staphylococcus spp., 28 Enterococcus spp., 14
Streptococcus spp., 33 fungi, and 3349 bacterial /antimicrobial
combinations, were analyzed in the RMAST investigation
(Table 4).
The RMAST was actually performed on 142 GN bacteria
(109 Enterobacteriaceae, 14 Acinetobacter spp., and 19 non-
fermentative bacteria), but two cultures (1 Acinetobacter junii,
1 Brevundimonas diminuta) grew poorly so were excluded from
the analysis. In total, 1828 bacterial/antimicrobial combinations
were analyzed with a category agreement of 96.77%, a mE rate of
2.52%, anME rate of 0.22%, and aVME rate of 0.49%. Errors were
found in Escherichia coli (1.09% mE, 0.05% ME, 0.27% VME),
Klebsiella pneumoniae (0.66% mE, 0.05% ME, 0.71% VME),
Enterobacter cloacae (0.22% mE), Enterobacter aerogenes (0.05%
mE),Morganella morganii (0.16%mE), Raoultella ornithinolytica
(0.11% mE), Providencia rettgeri (0.05% mE), Pseudomonas
aeruginosa (0.22% mE, 0.05% ME, 0.11% VME), and other non-
fermenters (0.22% mE, 0.11% ME, 0.05% VME).
Although, RMAST results were available for all 28
Enterococcus spp., they were available for only 105 of the
114 Staphylococcus spp.; 10 cases failed because of poor growth
(4 Staphylococcus epidermidis, 2 S. hominis, 1 S. capitis, 1
S. auricularis, 1 S. simulans, and 1 S. caprae). In total, 1246
bacterial/antimicrobial combinations were analyzed with a
category agreement of 93.50%, an mE rate of 3.69%, an ME
rate of 0.72%, and a VME rate of 2.09%. Errors were found
in S. aureus (0.32% mE, 0.16% VME), Coagulase-negative
staphylococcus (1.28% mE, 0.56% ME, 1.76% VME), and
Enterococci spp. (0.32% mE, 0.16% ME, 0.16% VME).
RMAST was originally performed on 21 Streptococcus spp.,
including 5 S. pneumoniae, 3 S. agalactiae, 1 S. pyogenes, and 12
S. viridians, but 7 of the S. viridans failed because of poor growth,
yielding 14 RMAST results. In total, 140 bacterial/antimicrobial
combinations were analyzed with a category agreement of
98.57%, an ME rate of 0.71%, and a VME rate of 0.71%.
RMAST results were available for 33 of the 37 fungal isolates (7
Candida albicans, 6 C. tropicalis, 3 C. parapsilosis, 3 C. glabrata, 1
C. lusitaniae, 1 Trichosporon asahii, 15 Cryptococcus neoformans,
and 1 C. albidus). Four cases (1 C. albicans, 1 C. parapsilosis, 1
C. glabrata, and 1 Cryptococcus albidus) grew poorly and were
thus excluded. In total, 90 bacterial/antimicrobial combinations
were analyzed with a category agreement of 95.56%, an mE rate
of 3.33% and a VME rate of 1.11% in the yeast group. Forty-five
bacterial/antimicrobial combinations were also analyzed with a
category agreement of 100% in the C. neoformans group.
Forty-three multi-drug resistant bacteria were detected in
this study, including 1 vancomycin-intermediate Staphylococcus
epidermidis, 1 vancomycin-resistant Enterococcus faecium, 1
linezolid-resistant S. aureus, 8 linezolid-resistant S. capitis, 16
carbapenem non-susceptible Enterobacteriaceae, 8 carbapenem
non-susceptible Acinetobacter spp., and 6 carbapenem
non-susceptible non-fermenting spp. The RMAST category
agreement of multi-drug resistant bacteria was 97.68%, with 1
mE in carbapenem non-susceptible Enterobacteriaceae.
Time to Identification and Antimicrobial
Susceptibility Testing
The average times of the RMI (vs. final identification report) were
0.58 h for GN, polymicrobial and sterile body fluid bacteria (vs.
18.1 h), 2.58 h for GP bacteria (vs. 18.1 h), 3.53 h for fungi (0.58 h
in sterile body fluid and 4.58 h in blood, vs. 32.2 h), 1.36 h for
anaerobic bacteria (0.58 h for GN and 2.58 h for GP bacteria, vs.
27.8 h), and 2.5 h for bacteria that failed to grow on the routing
plates (vs. 64 h). The results are presented in Figure 3.
The average times of RMAST (vs. the conventional method)
were 8.4 ± 2.6 h for GN bacteria (vs. 26.4 ± 2.6 h; p < 0.0001),
13.1 ± 3.0 h for GP bacteria (vs. 31.1 ± 3.0 h; p < 0.0001), 34 ±
12 h for fungi (vs. 58± 12 h; p < 0.0001; Figure 3).
Analysis of Clinical Relevance
Among 485 RMI cases (Figure 4), 14.85% of the results indicated
that clinicians should adjust their treatment. Specifically,
antibiotic therapy should be ceased in 3.71% of patients, initiated
in 9.28% of patients, and modified in 1.86% of patients. Among
the 320 RMAST results (Figure 4), 65% indicated that clinicians
could optimize the therapeutic regimen by de-escalating (51.6%)
or modifying (13.44%) the antibiotic therapy.
DISCUSSION
Sterile body fluid infections tend to trigger systemic or local tissue
damage. Because of their severity and morbidity, BSIs and acute
bacterial meningitis have placed a great burden on health care
settings (Adhikari et al., 2010; Thigpen et al., 2011; Goto and
Al-Hasan, 2013; Portnoy et al., 2015). Early diagnosis and rapid
intervention are critical to improving patient prognosis.
This study incorporated a combined MALDI–TOF MS/Vitek
AST system into the clinical microbiology laboratory workflow.
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TABLE 3 | RMI results of polymicrobial.
Species Correct ID Scores
Stenotrophomonas maltophilia/Staphylococcus haemolyticus Stenotrophomonas maltophilia 1.732
Klebsiella pneumoniae/Enterococcus faecalis Klebsiella pneumoniaEnterococcus faecalis 2.316/2.482
Enterobacter cloacae/Streptococcus oralis Not identified (very weak signal) N/A
Candida tropicalis/Acinetobacter baumannii Acinetobacter baumannii 1.703
Streptococcus oralis/Staphylococcus epidermidis Not identified (Misidentified for Staphylococcus warneri) 1.752
Acinetobacter baumannii/Klebsiella pneumoniae Klebsiella pneumoniae 2.176
Staphylococcus capitis/Klebsiella pneumoniae Staphylococcus capitis 1.739
Pseudomonas aeruginosa/Klebsiella pneumoniae Klebsiella pneumoniae 1.824
Pseudomonas aeruginosa/Klebsiella pneumoniae Klebsiella pneumoniae 2.219
Pseudomonas aeruginosa/Klebsiella pneumoniae Klebsiella pneumoniae 2.22
Staphylococcus epidermidis/Streptococcus salivarius Staphylococcus epidermidis 1.902
Enterococcus faecium/Staphylococcus haemolyticus Not identified (very weak signal) N/A
Staphylococcus haemolyticus/Staphylococcus capitis Staphylococcus capitis 1.749
Acinetobacter baumannii/Klebsiella pneumoniae Klebsiella pneumoniae 2.241
Staphylococcus aureus/Pantoea spp Staphylococcus aureus 1.715
Acinetobacter baumannii/Klebsiella pneumoniae Klebsiella pneumoniae 2.241
The aim was to provide clinicians with fast and accurate
identification results and multiple precise MIC values for
optimizing the therapeutic regimen.
Numerous strategies can identify RMI pathogens from
positive blood samples by MALDI–TOF MS (Hazelton et al.,
2014; Idelevich et al., 2014; Martinez et al., 2014; Schieffer et al.,
2014; Chan et al., 2015; Morgenthaler and Kostrzewa, 2015). The
RMI accuracy of GN and GP bacteria or yeasts identified by these
strategies has been widely reported, but the investigated species
were mostly single. Comprehensive analyses are relatively rare. In
this study, we collected 485 non-duplicated positive cultures from
blood, csf, ascitic fluid, vitreous fluid, and eye tissues samples, and
initiated by GN and GP bacteria, streptococci, fungi, fastidious
bacteria, anaerobic bacteria, polymicrobial, and bacteria that
failed to grow on the routing plates, and systematically evaluated
the accuracy and feasibility of RMI. Data showed the RMI
accuracies of CSF, ascitic fluid, vitreous fluid, and eye tissues
(almost 100%) were obviously higher than blood sample (57.1–
100%), especially for CSF, ascitic fluid, vitreous fluid, and eye
tissues samples which might attribute to the blood protein
interference. Moreover, the correct RMI rate of GN and GP
bacteria reached 98.9 and 87.2%, respectively, similar to the
results of previous studies (Hazelton et al., 2014; Schieffer et al.,
2014), whereas that of fungi (75.7%) was slightly higher than
in previous studies (Idelevich et al., 2014). We attribute this
improvement to the 4 h enrichment and constitution of the
sample source. The RMI accuracy of csf infections caused by
C. neoformans was especially high (100%, n = 9). Fastidious
bacteria yielded the least accurate results because they grow
poorly; this problem deserves further exploration. The dominant
species in polymicrobial was correctly identified in 81.2% of
cases. In addition, to the best of our knowledge, we were the
first to characterize the RMIs of rare bacteria that failed to grow
on routing plates (including Methylobacterium, Streptococcus
salivarius thermophilus, Staphylococcus saccharolyticus, and
Campylobacter fetus). The RMI accuracy reached 100% for these
species (n = 4), although the sample size was small, and
should be increased for an accurate evaluation. The accurate and
early detection of salmonella is important for the control and
prevention of hospital infections.
A variety of studies have focused on the resistance
determinants and activities of resistant enzymes (Majcherczyk
et al., 2006; Grundt et al., 2012; Hrabák et al., 2012; Chan et al.,
2015), but the obtained data were relatively scarce and unable
to provide accurate MIC values to clinicians (Idelevich et al.,
2014; Machen et al., 2014). Unlike the former methods, the Vitek
AST system is highly sensitive and well-standardized. In this
study, the category agreements of GN bacteria, Staphylococcus
and Enterococcus spp., Streptococcus spp., and fungi reached
96.77, 93.5, 98.57, and 95.56%, respectively, similarly to previous
studies (Romero-Gómez et al., 2012; Wimmer et al., 2012). The
percentage of major and very major errors was low among
the 3349 bacteria/antimicrobial combinations. In a RMAST of
GN bacteria, most of the VMEs (0.49%, n = 9) occurred
in amikacin, gentamicin, cefazolin, cefotetan, cefepime, and
piperacillin-tazobactam, as observed for E. coli and P. aeruginosa
in a previous study (Wimmer et al., 2012). Moreover, the present
study obtained VMEs from K. pneumoniae and other non-
fermenters. In the RMAST of Staphylococcus spp., most of the
VMEs (n = 26) occurred in the presence of gentamicin,
levofloxacin, clindamycin, and sulfamethoxazole/trimethoprim.
It is worth mentioning that the VITEK ATB AST system could
read the data automatically or semi-automatically. The automatic
interpretation of low-growth streptococcal and fungal species
could be supplemented by manual assistance. Thus, the RMAST
category agreement of fungi is obviously higher in our study
than in previous study (Idelevich et al., 2014). Importantly, the
RMAST category agreement of C. neoformans reached 100%.
Accurate RMI/RMAST results are useful for optimizing a
therapeutic regimen. First, the RMI and RMAST results are
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TABLE 4 | Bacterial/antimicrobial combinations and errors in bacterial isolates from positive-culture sterile body fluids.
Antimicrobial agent No Category agreement mE ME VME
GN BACTERIA (n = 140)
Amikacin 122 120 98.36% 1 0.82% 1 0.82%
Gentamicin 135 131 97.04% 3 2.22% 1 0.74%
Ciprofloxacin 135 131 97.04% 3 2.22% 1 0.74%
Ampicillin 117 117 100.0%
Cefazolin 135 127 94.07% 7 5.19% 1 0.74%
Cefotetan 135 129 95.56% 4 2.96% 2 1.48%
Ceftazidime 135 127 94.07% 6 4.44% 2 1.48%
Cefotaxime 135 134 99.26% 1 0.74%
Cefepime 135 123 91.11% 9 6.67% 3 2.22%
Imipenem 135 133 98.52% 2 1.48%
Ertapenem 112 112 100.0%
Piperacillin-tazobactam 122 116 95.08% 5 4.10% 1 0.82%
Sulfamethoxazole/trimethoprim 140 137 97.86% 2 1.43% 1 0.71%
Tobramycin 135 132 97.78% 3 2.22%
Total 1828 1769 96.77% 46 2.52% 4 0.22% 9 0.49%
STAPHYLOCOCCUS SPP (n = 105), ENTEROCOCCUS SPP (n = 28)
Penicillin 105 104 99.05% 1 0.95%
Oxacillin 105 104 99.05% 1 0.95%
Gentamicin 105 83 79.05% 10 9.52% 5 4.76% 7 6.67%
Levofloxacin 133 124 93.23% 6 4.51% 3 2.26%
Erythromycin 133 130 97.74% 2 1.50% 1 0.75%
Clindamycin 133 127 95.49% 4 3.01% 2 1.50%
Linezolid 133 133 100.0%
Vancomycin 133 133 100.0%
Rifampicin 105 105 100.0%
Sulfamethoxazole/trimethoprim 105 93 88.57% 1 0.95% 2 1.90% 9 8.57%
Ampicillin 28 4 14.29% 23 82.14% 1 3.57%
Gentamicin-High level 28 25 89.29% 2 7.14% 1 3.57%
Total 1246 1165 93.50% 46 3.69% 9 0.72% 26 2.09%
STREPTOCOCCUS SPP (n = 14)
Penicillin 14 13 92.86% 1 7.14%
Cefotaxime 14 14 100.0%
Ceftriaxone 5 5 100.0%
Imipenem 5 5 100.0%
Meropenem 5 5 100.0%
Levofloxacin 14 14 100.0%
Erythromycin 14 14 100.0%
Clindamycin 14 14 100.0%
Linezolid 5 5 100.0%
Vancomycin 14 14 100.0%
Quinuppistin-Dalfo 9 8 88.89% 1 11.11%
Tetracycline 9 9 100.0%
Chloramphenicol 9 9 100.0%
Sulfamethoxazole/trimethoprim 9 9 100.0%
Total 140 138 98.57% 1 0.71% 1 0.71%
(Continued)
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TABLE 4 | Continued
Antimicrobial agent No Category agreement mE ME VME
YEAST (n = 18)
5-Fluorocytosine 18 17 94.44% 1 5.56%
Fluconazole 18 17 94.44% 1 5.56%
Voriconazole 18 18 100.0%
Amphotericin B 18 18 100.0%
Itraconazole 18 16 88.89% 2 11.11%
Total 90 86 95.56% 3 3.33% 1 1.11%
CRYPTOCOCCUS NEOFORMANS (n = 15)
5-Fluorocytosine 15 15 100.0%
Fluconazole 15 15 100.0%
Amphotericin B 15 15 100.0%
Total 45 45 100.0%
The total numbers of isolates differed for each specific antimicrobial agent tested according to the CLSI (2015) guidelines.
FIGURE 3 | Comparison between the average times of RMI/RMAST
and FID/FAST. The average times of RMAST vs. the conventional method
were of great statistical significant (p < 0.0001). ***p < 0.0001. Bacteria failed
to grow: bacteria failed to grow on the routing plates.
returned at least 18–36 h earlier than the final reports. Notably,
the RMI of rare bacteria that failed to grow on routing plates
might be advanced by 66.5 h. Second, the RMI results may
accelerate the installation antibiotic therapy of BSIs caused
by S. aureus (8.45%), S. lugdunensis (not detected in the
present study) and Listeria monocytogenes (0.82%), which due
to morphology consistent with the contaminated bacteria and
gram stain are indistinguishable. The RMI also hastens the
modification of empirical antibiotic treatment in cases showing
intrinsic resistance (1.86% of cultures in the present study). From
another viewpoint, 3.71% of the cultures indicated cessation
of antibiotic therapy. Early recognitions of these contaminants
would avoid wastage of medical resources. Third, the RMAST
results provide a variety of accurate MIC values, by which
clinicians can choose drug multi-directionally and estimate
therapeutic doses precisely. In the present RMAST results,
13.44% of the cases showed resistance to last-resort antibiotics
(such as vancomycin, linezolid, and carbapenem), further
alerting clinicians to adjust the treatment or initiate essential
combination therapy. In contrast, 51.56% of the bacteria were
susceptible to third-generation cephalosporin and carbapenem
(GN bacteria) or vancomycin and linezolid (GP bacteria),
suggesting that antibiotic therapy might be de-escalated in
patients infected by these organisms.
In this study, we theoretically examined the utility of
RMI/RMAST in optimizing therapeutic regimens. We did
not conduct a practical investigation. Several studies (Martiny
et al., 2013; Perez et al., 2013) prospectively demonstrated
that rapid pathogen identification and antimicrobial stewardship
reduces the hospital length of stay and total costs. However,
these studies were limited to BSI caused by GN bacteria.
Therefore, we tentatively propose a protocol that establishes
the control and intervention groups and detects bacterial,
yeast and fungal infections in diverse sterile body fluids. The
impact of RMI/RMAST in decreasing the hospital length of
stay, cost, and antibiotic selective pressure deserves further
investigation.
CONCLUSIONS
The combined MALDI–TOF MS and Vitek AST system could
obtain a rapid, accurate, reliable identification, and ASTs reports.
The RMI and RMAST results not only reduce the turnaround
time of the patient, but also guide clinicians whether a
patient’s antibiotic treatment should be accelerated, ceased or de-
escalated, and adjusted the essential drugs modification for an
optimized therapy.
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